Official UK procurement notice
Inclusion - Supervised Consumption and Needle Exchange in Telford
Authority: Midlands Partnership Foundation Trust (NHS & healthcare)
What is being bought
Published requirement descriptionSupervised Consumption and Needle Exchange in Telford
CPV: Rehabilitation services
The lotProcurement structure
single lot · no lot value publishedLot #1Midlands Partnership NHS Foundation Trust is commissioned to provide Drug and Alcohol…Awarded
Midlands Partnership NHS Foundation Trust is commissioned to provide Drug and Alcohol Services and does this via their Inclusion directorate and with the support of third-party suppliers.
Provision of Pharmacy supervised self-administration of oral Opioid Substitution Therapy services qualify as locally Commissioned ‘enhanced’ Services under ‘The Contractual Framework for Community Pharmacy’ and as such participation by community pharmacists in this service remains voluntary and guided by localised need. Pharmacists participating in this service will be expected to dispense to the number of people that they feel appropriate for their pharmacy within the parameters of good practice advised by Inclusion Services, considering all their community responsibilities.
Dispensing opiate substitution therapy not, subject to supervised self-administration remains an essential service and remuneration for this is covered by PSNC.
Provision of Pharmacy needle syringe programme services qualify as locally Commissioned ‘enhanced’ Services under ‘The Contractual Framework for Community Pharmacy’ and as such participation by community pharmacists in this service remains voluntary and guided by localised need. Pharmacies participating in this service will be expected to take on the level of service that they feel appropriate for their pharmacy within the parameters of good practice advised by Inclusion Services, taking into account all their community responsibilities.
This award to various pharmacies has been made following a direct award B process, the lifetime value of this contract is £130,500.00 and will go live 1st May 2026 to 30th April 2029. This is an existing service for MPFT, and some pharmacies may be an existing provider or a new provider as all providers that are capable of providing this service have been offered contracts.
Procedure terms & legal framework
From the official record · publisher note attached- Procedure method
- Award procedure without prior publication of a call for competition
- Legal basis
- CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
- Procurement category
- Services
- Notice status
- Awarded without competition
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Stand-alone contract (no framework)
- Competition type
- Direct award (no call for competition)
- GPA / WTO covered
- Unspecified in notice
- Recurring procurement
- Unspecified in notice
- First published
- 12 Jun 2026, 10:11 BST
- Last source update
- 12 Jun 2026, 10:11 BST
- Authority reference
RRE-01670- FTS notice number
2026/S 000-055538- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-06b3baFind a Tender
- Why no open competition
- The procurement falls outside the scope of application of the directive
- Published justification
This is a Provider Selection Regime (PSR) confirmation of contract award notice. this contract has been awarded under the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award.
The contract has been awarded to a number of providers who are able to meet the specification, where people are offered a choice between the providers and this is not restricted. To ensure providers meet the specification this has been assessed by clinical and operational colleagues as key decision makers. There are no identified conflicts of interest
- Review procedure
All appeals should be raised in line with the prevailing legislation.
Publisher note: This is a Provider Selection Regime (PSR) confirmation of contract award notice. this contract has been awarded under the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. The contract has been awarded to a number of providers who are able to meet the specification, where people are offered a choice between the providers and this is not restricted. To ensure providers meet the specification this has been assessed by clinical and operational colleagues as key decision makers. There are no identified conflicts of interest
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast| Awarded to | Value | Date | Status |
|---|---|---|---|
| Pharmacies in Telford | £130,500 † | — | Awarded |
Contracts
Inclusion - Supervised Consumption and Needle Exchange in Telford · Pharmacies in Telford
- Signed
- 11 Jun 2026
- Value
- £130,500
- Status
- active
Bid statistics published by the authority
| Bids | SME | VCSE | Valid bid range |
|---|---|---|---|
| 1bids | — | — | — |
Contracting authority & participating public bodies
Dispute resolution & review bodies
- Midlands Partnersip NHS Foundation TrustReview body
Bidders & participating suppliers
1 commercial party on the notice- Pharmacies in TelfordAwarded supplier
Official documents & specifications
Official links; attachments are not copiedNo document links were published on the notice.